Search bioRxiv⌕ Search

Biology subjects

Kaznatcheev, A.

Publications and source records attributed to Kaznatcheev, A..

10 recordsLinked to original sources

Polymorphic Gompertzian model of cancer validated with in vitro and in vivo data

Mathematical modeling plays an important role in our understanding and targeting therapy resistance mechanisms in cancer. The polymorphic Gompertzian model, analyzed theoretically by Viossat and Noble, describes a heterogeneous cancer population consisting of therapy sensitive and resistant cells. This theoretically promising model has not previously been validated with real-world data. In this study, we provide this validation. We demonstrate that the polymorphic Gompertzian model successfully captures trends in both in vitro and in vivo data on non-small cell lung cancer (NSCLC) dynamics under treatment. Additionally, for the in vivo data of tumor dynamics in patients undergoing treatment, we compare the polymorphic Gompertzian model to the classical oncologic models, which were previously identified as the models that fit this data best. We show that the polymorphic Gompertzian model can successfully capture the U-shape trend in tumor size during cancer relapse, which can not be fitted with the classical oncologic models. In general, the polymorphic Gompertzian model corresponds well to both in vitro and in vivo real-world data, suggesting it as a candidate for improving the efficacy of cancer therapy, for example through evolutionary/adaptive therapies.

cancer biology↗

The cost of information acquisition by natural selection

Natural selection enriches genotypes that are well-adapted to their environment. Over successive generations, these changes to the frequencies of types accumulate information about the selective conditions. Thus, we can think of selection as an algorithm by which populations acquire information about their environment. Kimura (1961) pointed out that every bit of information that the population gains this way comes with a minimum cost in terms of unrealized fitness (substitution load). Due to the gradual nature of selection and ongoing mismatch of types with the environment, a population that is still gaining information about the environment has lower mean fitness than a counter-factual population that already has this information. This has been an influential insight, but here we find that experimental evolution of Escherichia coli with mutations in a RNA polymerase gene (rpoB) violates Kimuras basic theory. To overcome the restrictive assumptions of Kimuras substitution load and develop a more robust measure for the cost of selection, we turn to ideas from computational learning theory. We reframe the learning problem faced by an evolving population as a population versus environment (PvE) game, which can be applied to settings beyond Kimuras theory - such as stochastic environments, frequency-dependent selection, and arbitrary environmental change. We show that the learning theoretic concept of regret measures relative lineage fitness and rigorously captures the efficiency of selection as a learning process. This lets us establish general bounds on the cost of information acquisition by natural selection. We empirically validate these bounds in our experimental system, showing that computational learning theory can account for the observations that violate Kimuras theory. Finally, we note that natural selection is a highly effective learning process in that selection is an asymptotically optimal algorithm for the problem faced by evolving populations, and no other algorithm can consistently outperform selection in general. Our results highlight the centrality of information to natural selection and the value of computational learning theory as a perspective on evolutionary biology.

evolutionary biology↗

Understanding the Evolutionary Games in NSCLC Microenvironment

While initially highly successful, targeted therapies eventually fail as populations of tumor cells evolve mechanisms of resistance, leading to resumption of tumor growth. Historically, cell-intrinsic mutational changes have been the major focus of experimental and clinical studies to decipher origins of therapy resistance. While the importance of these mutational changes is undeniable, a growing body of evidence suggests that non-cell autonomous interactions between sub-populations of tumor cells, as well as with non-tumor cells within tumor microenvironment, might have a profound impact on both short term sensitivity of cancer cells to therapies, as well as on the evolutionary dynamics of emergent resistance. In contrast to well established tools to interrogate the functional impact of cell-intrinsic mutational changes, methodologies to understand non-cell autonomous interactions are largely lacking. Evolutionary Game Theory (EGT) is one of the main frameworks to understand the dynamics that drive frequency changes in interacting competing populations with different phenotypic strategies. However, despite a few notable exceptions, the use of EGT to understand evolutionary dynamics in the context of evolving tumors has been largely confined to theoretical studies. In order to apply EGT towards advancing our understanding of evolving tumor populations, we decided to focus on the context of the emergence of resistance to targeted therapies, directed against EML4-ALK fusion gene in lung cancers, as clinical responses to ALK inhibitors represent a poster child of limitations, posed by evolving resistance. To this end, we have examined competitive dynamics between differentially labelled therapy-naive tumor cells, cells with cell-intrinsic resistance mechanisms, and cells with cell-extrinsic resistance, mediated by paracrine action of hepatocyte growth factor (HGF), within in vitro game assays in the presence or absence of front-line ALK inhibitor alectinib. We found that producers of HGF were the fittest in every pairwise game, while also supporting the proliferation of therapy-naive cells. Both selective advantage of these producer cells and their impact on total population growth was a linearly increasing function of the initial frequency of producers until eventually reaching a plateau. Resistant cells did not significantly interact with the other two phenotypes. These results provide insights on reconciling selection driven emergence of subpopulations with cell non-cell autonomous resistance mechanisms, with lack of evidence of clonal dominance of these subpopulations. Further, our studies elucidate mechanisms for co-existence of multiple resistance strategies within evolving tumors. This manuscript serves as a technical report and will be followed up with a research paper in a different journal.

cancer biology↗

Dose dependent evolutionary game dynamics modulate competitive release in cancer therapy

Therapeutic strategies for tumor control have traditionally assumed that maximizing reduction in tumor volume correlates with clinical efficacy. Unfortunately, this rapid decrease in tumor burden is almost invariably followed by the emergence of therapeutic resistance. Evolutionary based treatment strategies attempt to delay resistance via judicious treatments that maintain a significant treatable subpopulation. While these strategies have shown promise in recent clinical trials, they often rely on biological conjecture and intuition to derive parameters. In this study we experimentally measure the frequency-dependent interactions between a gefitinib resistant non-small cell lung cancer (NSCLC) population and its sensitive ancestor via the evolutionary game assay. We show that cost of resistance is insufficient to accurately predict competitive exclusion and that frequency-dependent growth rate measurements are required. In addition, we show that frequency-dependent growth rate changes may ultimately result in a safe harbor for resistant populations to safely accumulate, even those with significant cost of resistance. Using frequency-dependent growth rate data we then show that gefitinib treatment results in competitive exclusion of the ancestor, while absence of treatment results in a likely, but not guaranteed exclusion of the resistant strain. Finally, using our empirically derived growth rates to constrain simulations, we demonstrate that incorporating ecological growth effects can dramatically change the predicted time to sensitive strain extinction. In addition, we show that higher drug concentrations may not lead to the optimal reduction in tumor burden. Taken together, these results highlight the potential importance of frequency-dependent growth rate data for understanding competing populations, both in the laboratory and the clinic.

cancer biology↗

Evolution is exponentially more powerful with frequency-dependent selection

Valiant [1] proposed to treat Darwinian evolution as a special kind of computational learning from statistical queries. The statistical queries represent a genotypes fitness over a distribution of challenges. And this distribution of challenges along with the best response to them specify a given abiotic environment or static fitness landscape. Valiants model distinguished families of environments that are "adaptable-to" from those that are not. But this model of evolution omits the vital ecological interactions between different evolving agents - it neglects the rich biotic environment that is central to the struggle for existence. In this article, I extend algorithmic Darwinism to include the ecological dynamics of frequency-dependent selection as a population-dependent bias to the distribution of challenges that specify an environment. Thus, extended algorithmic Darwinism suggests extended statistical queries rather than just statistical queries as the appropriate model for eco-evo dynamics. This extended algorithmic Darwinism replaces simple invasion of wild-type by a mutant-type of higher scalar fitness with an evolutionary game between wild-type and mutant-type based on their frequency-dependent fitness function. To analyze this model, I develop a game landscape view of evolution, as a generalization of the classic fitness landscape approach. I show that this model of eco-evo dynamics on game landscapes can provide an exponential speed-up over the purely evolutionary dynamics of the strict algorithmic Darwinism. In particular, I prove that the Parity environment - which is known to be not adaptable-to under strict algorithmic Darwinism - is adaptable-to by eco-evo dynamics. Thus, the ecology of frequency-dependent selection does not just increase the tempo of evolution, but fundamentally transforms its mode. This happens even if frequency-dependence is restricted to short-time scales - such short bursts of frequency-dependent selection can have a transformative effect on the ability of populations to adapt to their environments in the long-term. Unlike typical learning algorithms, the eco-evo dynamic for adapting to the Parity environment does not rely on Gaussian elimination. Instead, the dynamics proceed by simple isotropic mutations and selection in finite populations of just two types (the resident wild-type and invading mutant). The resultant process has two stages: (1) a quick stage of point-mutations that moves the population to one of exponentially many local fitness peaks; followed by (2) a slower stage where each step follows a double-mutation by a point-mutation. This second stage allows the population to hop between local fitness peaks to reach the unique global fitness peak in polynomial time. The evolutionary game dynamics of finite populations are essential for finding a short adaptive path to the global fitness peak during the second stage of the adaptation process. This highlights the rich interface between computational learning theory, analysis of algorithms, evolutionary games, and long-term evolution.

evolutionary biology↗

Fractionated follow-up chemotherapy delays the onset of resistance in bone metastatic prostate cancer

Prostate cancer to bone metastases are almost always lethal. This results from the ability of metastatic prostate cancer cells to co-opt bone remodeling leading to what is known as the vicious cycle. Understanding how tumor cells can disrupt bone homeostasis through their interactionswith the stroma and how metastatic tumors respond to treatment is key to the development of new treatments for what remains an incurable disease. Here we describe an evolutionary game theoretical model of both the homeostatic bone remodeling and its co-option by prostate cancer metastases. This model extends past the evolutionary aspects typically considered in game theoretical models by also including ecological factors such as the physical microenvironment of the bone. Our model recapitulates the current paradigm of the \"vicious cycle\" driving tumor growth and sheds light on the interactions of heterogeneous tumor cells with the bone microenvironment and treatment response. Our results show that resistant populations naturally become dominant in the metastases under conventional cytotoxic treatment and that novel schedules could be used to better control the tumor and the associated bone disease compared to the current standard of care. Specifically, we introduce fractionated follow up therapy - chemotherapy where dosage is administered initially in one solid block followed by alternating smaller doeses and holidays - and argue that it is better than either a continuous application or a periodic one. Furthermore, we also show that different regimens of chemotherapy can lead to different amounts of pathological bone that are known to correlate with poor quality of life for bone metastatic prostate cancer patients.

cancer biology↗

Two conceptions of evolutionary games: reductive vs effective

Evolutionary game theory (EGT) was born from economic game theory through a series of analogies. Given this heuristic genealogy, a number of central objects of the theory (like strategies, players, and games) have not been carefully defined or interpreted. A specific interpretation of these terms becomes important as EGT sees more applications to understanding experiments in microscopic systems typical of oncology and microbiology. In this essay, I provide two interpretations of the central objects of games theory: one that leads to reductive games and the other to effective games. These interpretation are based on the difference between views of fitness as a property of individuals versus fitness as a summary statistic of (sub)populations. Reductive games are typical of theoretical work like agent-based models. But effective games usually correspond more closely to experimental work. However, confusing reductive games for effective games or vice-versa can lead to divergent results, especially in spatially structured populations. As such, I propose that we treat this distinction carefully in future work at the interface of EGT and experiment.

evolutionary biology↗

Dark selection for JAK/STAT-inhibitor resistance in chronic myelomonocytic leukemia

Acquired therapy resistance to cancer treatment is a common and serious clinical problem. The classic U-shape model for the emergence of resistance supposes that: (1) treatment changes the selective pressure on the treatment-naive tumour; (2) this shifting pressure creates a proliferative or survival difference between sensitive cancer cells and either an existing or de novo mutant; (3) the resistant cells then out-compete the sensitive cells and - if further interventions (like drug holidays or new drugs or dosage changes) are not pursued - take over the tumour: returning it to a state dangerous to the patient. The emergence of ruxolitinib resistance in chronic myelomonocytic leukemia (CMML) seems to challenge the classic model: we see the global properties of resistance, but not the drastic change in clonal architecture expected with the selection bottleneck. To study this, we explore three population-level models as alternatives to the classic model of resistance. These three effective models are designed in such a way that they are distinguishable based on limited experimental data on the time-progression of resistance in CMML. We also propose a candidate reductive implementation of the proximal cause of resistance to ground these effective theories. With these reductive implementations in mind, we also explore the impact of oxygen diffusion and spatial structure more generally on the dynamics of CMML in the bone marrow concluding that, even small fluctuations in oxygen availability can seriously impact the efficacy of ruxolitinib. Finally, we look at the ability of spatially distributed cytokine signaling feedback loops to produce a relapse in symptoms similar to what we observe in the clinic.

cancer biology↗

Complexity of evolutionary equilibria in static fitness landscapes

Experiments show that evolutionary fitness landscapes can have a rich combinatorial structure due to epistasis. For some landscapes, this structure can produce a computational constraint that prevents evolution from finding local fitness optima - thus overturning the traditional assumption that local fitness peaks can always be reached quickly if no other evolutionary forces challenge natural selection. Here, I introduce a distinction between easy landscapes of traditional theory where local fitness peaks can be found in a moderate number of steps and hard landscapes where finding local optima requires an infeasible amount of time. Hard examples exist even among landscapes with no reciprocal sign epistasis; on these semi-smooth fitness landscapes, strong selection weak mutation dynamics cannot find the unique peak in polynomial time. More generally, on hard rugged fitness landscapes that include reciprocal sign epistasis, no evolutionary dynamics - even ones that do not follow adaptive paths - can find a local fitness optimum quickly. Moreover, on hard landscapes, the fitness advantage of nearby mutants cannot drop off exponentially fast but has to follow a power-law that long term evolution experiments have associated with unbounded growth in fitness. Thus, the constraint of computational complexity enables open-ended evolution on finite landscapes. Knowing this constraint allows us to use the tools of theoretical computer science and combinatorial optimization to characterize the fitness landscapes that we expect to see in nature. I present candidates for hard landscapes at scales from single genes, to microbes, to complex organisms with costly learning (Baldwin effect) or maintained cooperation (Hankshaw effect). Just how ubiquitous hard landscapes (and the corresponding ultimate constraint on evolution) are in nature becomes an open empirical question.

evolutionary biology↗

Cancer associated fibroblasts and alectinib switch the evolutionary games that non-small cell lung cancer plays

Heterogeneity in strategies for survival and proliferation among the cells which constitute a tumour is a driving force behind the evolution of resistance to cancer therapy. The rules mapping the tumours strategy distribution to the fitness of individual strategies can be represented as an evolutionary game. We develop a game assay to measure effective evolutionary games in co-cultures of non-small cell lung cancer cells which are sensitive and resistant to the anaplastic lymphoma kinase inhibitor Alectinib. The games are not only quantitatively different between different environments, but targeted therapy and cancer associated fibroblasts qualitatively switch the type of game being played by the in-vitro population from Leader to Deadlock. This observation provides empirical confirmation of a central theoretical postulate of evolutionary game theory in oncology: we can treat not only the player, but also the game. Although we concentrate on measuring games played by cancer cells, the measurement methodology we develop can be used to advance the study of games in other microscopic systems by providing a quantitative description of non-cell-autonomous effects.

cancer biology↗